Hrt Financial LP Arbutus Biopharma Corp Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.98 - $3.17 $100,221 - $160,455	-50,617 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.42 - $3.98 $122,493 - $201,455	50,617 New	50,617 $150,000
Q4 2021 Feb 14, 2022	SELL	$3.11 - $4.61 $58,231 - $86,317	-18,724 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $49,618 - $86,504	18,724 New	18,724 $80,000
Q1 2021 May 17, 2021	SELL	$3.14 - $4.84 $88,089 - $135,781	-28,054 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.76 - $4.97 $77,429 - $139,428	28,054 New	28,054 $99,000
Q2 2020 Aug 14, 2020	SELL	$0.91 - $2.36 $10,647 - $27,612	-11,700 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.01 - $3.42 $33,523 - $113,516	-33,192 Reduced 73.94%	11,700 $11,000
Q4 2019 Feb 14, 2020	BUY	$0.87 - $2.89 $39,056 - $129,737	44,892 New	44,892 $124,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.